|
1
|
Mahieu NN, Witvrouw E, Stevens V, Van
Tiggelen D and Roget P: Intrinsic risk factors for the development
of achilles tendon overuse injury: A prospective study. Am J Sports
Med. 34:226–235. 2006. View Article : Google Scholar
|
|
2
|
Maffulli N: Achilles tendon pathology,
present and future. Br J Sports Med. 45:e2 View Article : Google Scholar : 2011.
|
|
3
|
Zhang J and Wang JH: Characterization of
differential properties of rabbit tendon stem cells and tenocytes.
BMC Musculoskelet Disord. 11:102010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bi Y, Ehirchiou D, Kilts TM, Inkson CA,
Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, et al:
Identification of tendon stem/progenitor cells and the role of the
extracellular matrix in their niche. Nat Med. 13:1219–1227. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rui YF, Lui PP, Li G, Fu SC, Lee YW and
Chan KM: Isolation and characterization of multipotent rat
tendon-derived stem cells. Tissue Eng Part A. 16:1549–1558. 2010.
View Article : Google Scholar
|
|
6
|
Zhang J and Wang JH: Production of PGE(2)
increases in tendons subjected to repetitive mechanical loading and
induces differentiation of tendon stem cells into non-tenocytes. J
Orthop Res. 28:198–203. 2010.
|
|
7
|
de Mos M, Koevoet WJ, Jahr H, Verstegen
MM, Heijboer MP, Kops N, van Leeuwen JP, Weinans H, Verhaar JA and
van Osch GJ: Intrinsic differentiation potential of adolescent
human tendon tissue: An in-vitro cell differentiation study. BMC
Musculoskelet Disord. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salingcarnboriboon R, Yoshitake H, Tsuji
K, Obinata M, Amagasa T, Nifuji A and Noda M: Establishment of
tendon-derived cell lines exhibiting pluripotent mesenchymal stem
cell-like property. Exp Cell Res. 287:289–300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blander G and Guarente L: The Sir2 family
of protein deacetylases. Annu Rev Biochem. 73:417–435. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen-Kfir E, Artsi H, Levin A, Abramowitz
E, Bajayo A, Gurt I, Zhong L, D'Urso A, Toiber D, Mostoslavsky R
and Dresner-Pollak R: Sirt1 is a regulator of bone mass and a
repressor of Sost encoding for sclerostin, a bone formation
inhibitor. Endocrinology. 152:4514–4524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Backesjo CM, Li Y, Lindgren U and Haldosén
LA: Activation of Sirt1 decreases adipocyte formation during
osteoblast differentiation of mesenchymal stem cells. Cells Tissues
Organs. 189:93–97. 2009. View Article : Google Scholar
|
|
12
|
Liu J, Chen L, Tao X and Tang K:
Phosphoinositide 3-kinase/Akt signaling is essential for
prostaglandin E2-induced osteogenic differentiation of rat tendon
stem cells. Biochem Biophys Res Commun. 435:514–519. 2013.
View Article : Google Scholar
|
|
13
|
Liu J, Chen L, Zhou Y, Liu X and Tang K:
Insulin-like growth factor-1 and bone morphogenetic protein-2
jointly mediate prostaglandin e2-induced adipogenic differentiation
of rat tendon stem cells. PloS one. 9:e854692014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hata K, Nishimura R, Ikeda F, Yamashita K,
Matsubara T, Nokubi T and Yoneda T: Differential roles of Smad1 and
p38 kinase in regulation of peroxisome proliferator-activating
receptor gamma during bone morphogenetic protein 2-induced
adipogenesis. Mol Biol Cell. 14:545–555. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji C, Chang W, Centrella M and McCarthy
TL: Activation domains of CCAAT enhancer binding protein delta:
Regions required for native activity and prostaglandin E2-dependent
transactivation of insulin-like growth factor I gene expression in
rat osteoblasts. Mol Endocrinol. 17:1834–1843. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simic P, Zainabadi K, Bell E, Sykes DB,
Saez B, Lotinun S, Baron R, Scadden D, Schipani E and Guarente L:
SIRT1 regulates differentiation of mesenchymal stem cells by
deacetylating β-catenin. EMBO Mol Med. 5:430–440. 2013. View Article : Google Scholar : PubMed/NCBI
|
